Broadwood Partners, L.P. Acquires 249,503 Shares of STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical (NASDAQ:STAA) major shareholder Broadwood Partners, L.P. acquired 249,503 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was bought at an average price of $16.64 per share, for a total transaction of $4,151,729.92. Following the completion of the acquisition, the insider now owns 11,953,198 shares in the company, valued at approximately $198,901,214.72. The trade was a 2.13 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Broadwood Partners, L.P. also recently made the following trade(s):

• On Thursday, February 27th, Broadwood Partners, L.P. purchased 259,316 shares of STAAR Surgical stock. The shares were purchased at an average price of $17.05 per share, with a total value of $4,421,337.80.
• On Friday, February 14th, Broadwood Partners, L.P. bought 36,532 shares of STAAR Surgical stock. The stock was purchased at an average cost of $15.49 per share, with a total value of $565,880.68.
• On Wednesday, February 12th, Broadwood Partners, L.P. purchased 259,616 shares of STAAR Surgical stock. The shares were acquired at an average cost of $14.96 per share, for a total transaction of $3,883,855.36.
• On Thursday, January 16th, Broadwood Partners, L.P. acquired 8,221 shares of STAAR Surgical stock. The stock was acquired at an average price of $21.50 per share, with a total value of $176,751.50.
• On Tuesday, January 14th, Broadwood Partners, L.P. bought 21,155 shares of STAAR Surgical stock. The shares were acquired at an average price of $21.46 per share, for a total transaction of $453,986.30.
• On Wednesday, December 18th, Broadwood Partners, L.P. purchased 23,000 shares of STAAR Surgical stock. The stock was acquired at an average price of $24.33 per share, with a total value of $559,590.00.
• On Monday, December 16th, Broadwood Partners, L.P. acquired 53,500 shares of STAAR Surgical stock. The stock was bought at an average price of $24.24 per share, for a total transaction of $1,296,840.00.

STAAR Surgical Trading Up 7.8 %

Shares of NASDAQ:STAA opened at $17.75 on Wednesday. The firm has a 50 day simple moving average of $21.41 and a 200-day simple moving average of $27.04. STAAR Surgical has a twelve month low of $13.50 and a twelve month high of $52.68. The company has a market capitalization of $875.52 million, a PE ratio of -43.29 and a beta of 0.62.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on STAA shares. Jefferies Financial Group downgraded STAAR Surgical from a “buy” rating to a “hold” rating in a report on Wednesday, February 12th. William Blair cut shares of STAAR Surgical from an “outperform” rating to a “market perform” rating in a report on Wednesday, February 12th. Needham & Company LLC reiterated a “hold” rating on shares of STAAR Surgical in a research note on Thursday, February 27th. StockNews.com downgraded shares of STAAR Surgical from a “hold” rating to a “sell” rating in a research report on Thursday, February 13th. Finally, BTIG Research cut shares of STAAR Surgical from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 12th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, STAAR Surgical currently has an average rating of “Hold” and a consensus target price of $26.86.

Institutional Investors Weigh In On STAAR Surgical

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Arcadia Investment Management Corp MI purchased a new position in shares of STAAR Surgical during the third quarter worth about $37,000. Quarry LP acquired a new stake in shares of STAAR Surgical in the 3rd quarter valued at about $50,000. Quest Partners LLC purchased a new position in STAAR Surgical during the 3rd quarter worth approximately $128,000. Van ECK Associates Corp increased its position in STAAR Surgical by 12.7% during the third quarter. Van ECK Associates Corp now owns 3,478 shares of the medical instruments supplier’s stock worth $129,000 after buying an additional 393 shares during the period. Finally, Larson Financial Group LLC lifted its stake in STAAR Surgical by 78.3% in the third quarter. Larson Financial Group LLC now owns 4,863 shares of the medical instruments supplier’s stock valued at $181,000 after buying an additional 2,135 shares during the last quarter. 96.70% of the stock is owned by hedge funds and other institutional investors.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.